Impact of BAFF Gene Polymorphisms on the Risk of Ulcerative Colitis and the Efficacy of Vedolizumab.

N/ACompletedNCT07564895

Second Affiliated Hospital of Wenzhou Medical University841 enrolled

Overview

Relationships of B-cell Activating Factor Gene Polymorphisms With ulcerative colitis.

Study Type

OBSERVATIONAL

Enrollment

841

Conditions

Ulcerative Colitis (UC)

Eligibility

Sex: ALLMin age: 18 YearsMax age: 70 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * diagnosed UC based on comprehensive clinical, colonoscopy, histopathological, laboratory, and radiographic examination results Exclusion Criteria: * rheumatoid arthritis, systemic lupus erythematosus, intestinal tuberculosis, ischemic enteritis, radiation enteritis, tumors, etc

Locations (1)

the Second Affiliated Hospital of Wenzhou Medical University

Wenzhou, Zhejiang, China

Outcomes

Primary Outcomes

the genotypes of BAFF

multiplex polymerase chain reaction-ligase detection reaction technique

Time frame: Baseline

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.